CA999293A - .alpha.-AMINO-P-HYDROXYPHENYLACETAMIDOCEPHALOSPORINS - Google Patents

.alpha.-AMINO-P-HYDROXYPHENYLACETAMIDOCEPHALOSPORINS

Info

Publication number
CA999293A
CA999293A CA167,072A CA167072A CA999293A CA 999293 A CA999293 A CA 999293A CA 167072 A CA167072 A CA 167072A CA 999293 A CA999293 A CA 999293A
Authority
CA
Canada
Prior art keywords
hydroxyphenylacetamidocephalosporins
alpha
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA167,072A
Other versions
CA167072S (en
Inventor
John R.E. Hoover
George L. Dunn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Inc
Original Assignee
Smith Kline and French Canada Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US262903A external-priority patent/US3867380A/en
Priority claimed from US00289499A external-priority patent/US3855213A/en
Application filed by Smith Kline and French Canada Ltd filed Critical Smith Kline and French Canada Ltd
Application granted granted Critical
Publication of CA999293A publication Critical patent/CA999293A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
CA167,072A 1972-06-14 1973-03-26 .alpha.-AMINO-P-HYDROXYPHENYLACETAMIDOCEPHALOSPORINS Expired CA999293A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US262903A US3867380A (en) 1971-02-18 1972-06-14 3-Heterocyclic thiomethylcephalosporins
US00289499A US3855213A (en) 1971-02-18 1972-09-15 3-heterocyclic thiomethyl-cephalosporins

Publications (1)

Publication Number Publication Date
CA999293A true CA999293A (en) 1976-11-02

Family

ID=26949532

Family Applications (2)

Application Number Title Priority Date Filing Date
CA163,909A Expired CA1076560A (en) 1972-06-14 1973-02-16 3-heterocyclic thiomethylcephalosporins
CA167,072A Expired CA999293A (en) 1972-06-14 1973-03-26 .alpha.-AMINO-P-HYDROXYPHENYLACETAMIDOCEPHALOSPORINS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA163,909A Expired CA1076560A (en) 1972-06-14 1973-02-16 3-heterocyclic thiomethylcephalosporins

Country Status (20)

Country Link
JP (2) JPS5518716B2 (en)
AR (1) AR197237A1 (en)
AT (1) AT324560B (en)
AU (1) AU464107B2 (en)
CA (2) CA1076560A (en)
CH (2) CH589093A5 (en)
DD (1) DD105238A5 (en)
DE (1) DE2316867C2 (en)
DK (1) DK142913B (en)
ES (2) ES412207A1 (en)
FI (1) FI56843C (en)
FR (2) FR2187298B1 (en)
GB (2) GB1363833A (en)
HU (1) HU168689B (en)
IE (2) IE37409B1 (en)
IL (1) IL42126A (en)
NL (2) NL7302817A (en)
PH (1) PH9941A (en)
PL (1) PL91074B1 (en)
SE (2) SE416472B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR780000197B1 (en) * 1972-12-26 1978-05-26 Bristol Myers Co Method for preparing antibacterial agent
CA1035353A (en) * 1973-01-31 1978-07-25 Lee C. Cheney 3-thiolated-7-acylamidocephalosporanic acids
GB1476981A (en) * 1974-06-05 1977-06-16 Bristol Myers Co Substituted penicillanic acids
CA1074784A (en) * 1974-09-06 1980-04-01 Sumitomo Chemical Company N-ACYLAMINO-.alpha.-ARYLACETAMIDO CEPHALOSPORINS
JPS5346995A (en) * 1976-10-12 1978-04-27 Sangyo Kagaku Kenkyu Kyokai Antibacterial agents
NL162387C (en) * 1977-09-06 1980-05-16 Gist Brocades Nv PROCESS FOR PREPARING 6- (D-ALPHA-AMINO-P- HYDROXYPHENYLACETAMIDO) PENICILLANIC ACID.
JPS6010226U (en) * 1983-06-30 1985-01-24 松下電工株式会社 lift device
JPS6182606A (en) * 1984-09-29 1986-04-26 東芝ライテック株式会社 Lift

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA698494B (en) * 1969-02-26 1971-07-28 Lilly Co Eli Sulfur-containing cephalosporing antibiotics
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Also Published As

Publication number Publication date
IE37409L (en) 1973-12-14
CA1076560A (en) 1980-04-29
CH586709A5 (en) 1977-04-15
GB1358027A (en) 1974-06-26
IE37499B1 (en) 1977-08-03
NL7302817A (en) 1973-12-18
HU168689B (en) 1976-06-28
SE416472B (en) 1981-01-05
DD105238A5 (en) 1974-04-12
FR2187298B1 (en) 1976-12-03
DE2316867C2 (en) 1982-05-19
FR2187298A1 (en) 1974-01-18
PL91074B1 (en) 1977-02-28
ES413501A1 (en) 1976-07-16
IE37499L (en) 1973-12-14
IL42126A (en) 1975-12-31
FR2187299A1 (en) 1974-01-18
AR197237A1 (en) 1974-03-22
IE37409B1 (en) 1977-07-20
PH9941A (en) 1976-06-14
DE2316866B2 (en) 1976-10-07
CH589093A5 (en) 1977-06-30
ES412207A1 (en) 1976-01-01
JPS5953274B2 (en) 1984-12-24
JPS5518716B2 (en) 1980-05-21
FI56843B (en) 1979-12-31
AU5234573A (en) 1974-08-22
SE404190B (en) 1978-09-25
AU464107B2 (en) 1975-08-14
DE2316866A1 (en) 1974-01-03
AT324560B (en) 1975-09-10
IL42126A0 (en) 1973-06-29
DK142913C (en) 1981-09-28
GB1363833A (en) 1974-08-21
DE2316867A1 (en) 1974-01-03
NL7305206A (en) 1973-12-18
JPS4954393A (en) 1974-05-27
FI56843C (en) 1980-04-10
JPS4931689A (en) 1974-03-22
DK142913B (en) 1981-02-23
FR2187299B1 (en) 1976-12-03

Similar Documents

Publication Publication Date Title
CA996548A (en) .alpha.-SULFOBENZYLPENICILLIN SALT
AU462348B2 (en) Saf-t-jet
AU467469B2 (en) Trifluoromethylmercaptoacetamindocephalosphorins
AU454372B2 (en) Childsafe actuator-overcap
CA978946A (en) .alpha.-ARYL-4-SUBSTITUTED PIPERIDINOALKANOL DERIVATIVES
AU469305B2 (en) Deipenylyl-alkanoylaminopyridine
CA999293A (en) .alpha.-AMINO-P-HYDROXYPHENYLACETAMIDOCEPHALOSPORINS
CA960666A (en) 1-aminomethyl-2,2-diaryl-cyclo-propanecarboxamides
CA1026347A (en) 1-ethyl-imidazoles
CA1024149A (en) 4.alpha.-ARYL-TRANS-DECAHYDROISOQUINOLINES
AU466344B2 (en) Cycloalkyllactamimides
AU468159B2 (en) 5-aroyl-furans
CA1013742A (en) Azabenzo-1,5-diazepines
CA1007662A (en) .alpha.(-AMINOALKYL-4-HYDROXY-3-ALKYLSULFONYLMETHYL-BENZYL ALCOHOLS
AU467008B2 (en) d, d-DIARYLIMIDAZOLE-2-METHANOLS
AU467526B2 (en) Pyronorifamycins
AU468236B2 (en) 2-acyl-5-nitrothiazoles
AU468599B2 (en) 15-oxasteroids
CA904318A (en) .alpha.-POLYHYDROXYPHENYL-2-PIPER-IDINEMETHANOLS
CA900985A (en) .alpha.-CARBOLINES
CA900984A (en) .alpha.-CARBOLINES
CA907632A (en) .alpha.-HALO-PHENYLACETAMIDES
CA902108A (en) .alpha.-PROPARGYLAMINOPROPIOPHENONE DERIVATIVE
CA902040A (en) 7 .alpha.-METHYL-ANDROSTENOLONES
CA910307A (en) 7-MERCAPTO-7-DEOXY-.alpha.-THIOLINCOSAMINIDES